Medicinova, Inc. v. Genzyme Corporation

Good Law
United States District Court, Southern District of CaliforniaJuly 20, 20213:14-cv-02513California8,060 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 MEDICINOVA, INC., Case No.: 14-CV-2513 JLS (KSC) a Delaware Corporation,

ORDER (1) DENYING

Plaintiff, DEFENDANT’S MOTION FOR v. ATTORNEYS’ FEES UNDER 35

U.S.C. § 285 AND (2) GRANTING IN

GENZYME CORPORATION,

PART AND DENYING IN PART a Massachusetts Corporation,

DEFENDANT’S BILL OF COSTS

16 Defendant. (ECF Nos. 158–159)

Presently before the Court are Defendant Genzyme Corporation’s Motion for Attorneys’ Fees Under 35 U.S.C. § 285 (“Mot.,” ECF No. 158-1) and Bill of Costs (“Bill,” ECF No. 159). Plaintiff Medicinova, Inc. filed a Response in Opposition to (“Fees Opp’n,” ECF No. 162) the Motion, and Defendant filed a Reply in Support of (“Reply,” ECF No. 163) the Motion. Plaintiff also filed an Opposition in Part to Defendant’s Bill of Costs (“Costs Opp’n,” ECF No. 161). The Court took the matter under submission without oral 25 …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.